Meningococcal AC vaccine (Beijing Zhifei Luzhu Biopharmaceutical)

A群C群脑膜炎球菌多糖结合疫苗（智飞生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal AC vaccine (Beijing Zhifei Luzhu Biopharmaceutical)
Drug Alias NameMeningACon盟纳康
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSepsisEpiglottitisPneumonia +[6] 
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaMeningitis, Meningococcal
Original Approved Country/TerritoryMainland China
Original Approved Date2007/08/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSepsisEpiglottitisPneumonia +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH03
Related LinksN/A